200
Participants
Start Date
April 26, 2019
Primary Completion Date
April 4, 2024
Study Completion Date
May 29, 2026
Daratumumab
Daratumumab 1800 mg will be administered by SC injection weekly during Cycles 1 and 2, every 2 weeks during Cycles 3 through 6, and every 4 weeks from Cycle 7 onward until confirmed progressive disease (PD), unacceptable toxicity, or until end of study treatment for a maximum of 36 cycles.
Lenalidomide
Lenalidomide 10 mg will be administered orally from Day 1 to Day 28 (continuously) of each 28-day cycle until confirmed PD, unacceptable toxicity, or until end of study treatment for a maximum of 36 cycles. After 3 cycles of maintenance therapy, if well tolerated, the lenalidomide dose may be increased to 15 mg daily, at the discretion of the investigator.
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
Montefiore Einstein Center for Cancer Care, The Bronx
Northwell Health, Lake Success
NYU Winthrop, Mineola
New York Oncology Hematology, Albany
SUNY Upstate Medical University, Syracuse
West Penn Hospital, Pittsburgh
University Of Pittsburgh Medical Center UPMC Hillman Cancer Center, Pittsburgh
Fox Chase Cancer Center, Philadelphia
Reading Hospital/McGlinn Cancer Institute, West Reading
MedStar Georgetown University Hospital, Washington D.C.
University of Maryland Greenebaum Cancer Center, Baltimore
Virginia Cancer Specialists, Fairfax
University of Virginia Cancer Center - Emily Couric Clinical Cancer Center - Women's Oncology Clinic, Charlottesville
Virginia Oncology Associates, Norfolk
Novant Oncology Research Institute, Winston-Salem
Wake Forest Health Sciences, Winston-Salem
Levine Cancer Institute, Carolinas HealthCare System, Charlotte
Novant Health, Charlotte
Spartanburg Regional Health Services, Spartanburg
University Cancer And Blood Center LLC, Athens
Cancer Specialists of North Florida, Jacksonville
University of Miami Sylvester Cancer Center, Miami
Miami Cancer Institute, Miami
Cleveland Clinic Florida, Weston
Moffitt Cancer Center, Tampa
University of Alabama Birmingham, Birmingham
Tennessee Oncology, Nashville
Tennessee Oncology, Chattanooga
Baptist Cancer Center, Memphis
University of Mississippi Medical Center, Jackson
Norton Cancer Institute, Louisville
Oncology Hematology Care, Cincinnati
Fort Wayne Medical Oncology and Hematology American Oncology Partners, Fort Wayne
Cancer And Hematology Centers of Western Michigan PC, Grand Rapids
Cancer Treatment Centers of America, Zion
Illinois Cancer Specialists, Niles
HCA MidAmerica Division Inc Research Medical Center, Kansas City
University of Kansas Cancer Center, Westwood
Ochsner Clinic Foundation, New Orleans
UT Southwestern Medical Center, Dallas
Texas Oncology P A, Dallas
Texas Oncology P A, Tyler
MD Anderson Cancer Center, Houston
Mays Cancer Center (UT Health San Antonio), San Antonio
Texas Oncology-Central South, Austin
Colorado Blood Cancer Institute, Denver
Rocky Mountain Cancer Centers, Denver
University of Colorado Health, Fort Collins
Huntsman Cancer Institute, Salt Lake City
Arizona Oncology Associates, PC - HAL, Glendale
Cancer Treatment Center of America Phoenix, Goodyear
UCLA David Geffen School of Medicine, Los Angeles
University of California San Diego (UCSD) - The Rebecca and John Moores Cancer Center, La Jolla
University of California San Francisco, San Francisco
Northwest Cancer Specialists PC, Portland
Oregon Health And Science University, Portland
VA Puget Sound Healthcare System, Seattle
University of Washington, Seattle
Cancer Care Northwest, Spokane
Yale University Medical Center, New Haven
Franciscan Health, Indianapolis
Beth Israel Deaconess Medical Center, Boston
Henry Ford Cancer Institute, Detroit
Summit Medical Group/MD Anderson Cancer Center, Florham Park
Rutgers, The State Univ of NJ-Robert Wood Johnson Medical School-The Cancer Institute of NJ (CINJ), New Brunswick
University of North Carolina, Chapel Hill
Thomas Jefferson University, Philadelphia
Greenville Health System Cancer Institute, Greenville
Princess Margaret Hospital, Toronto
McGill University Health Centre, Montreal
CHU de Quebec Universite Laval Hopital de l Enfant Jesus, Québec
Janssen Research & Development, LLC
INDUSTRY